Millions of people with substance use disorders (SUDs) need, but do not receive, treatment. Delivering SUD treatment in primary care settings could increase access to treatment because most people visit their primary care doctors at least once a year, but evidence-based SUD treatments are underutilized in primary care settings. We used an organizational readiness intervention comprised of a cluster of implementation strategies to prepare a federally qualified health center to deliver SUD screening and evidence-based treatments (extended-release injectable naltrexone (XR-NTX) for alcohol use disorders, buprenorphine/naloxone (BUP/NX) for opioid use disorders and a brief motivational interviewing/cognitive behavioral –based psychotherapy for both disorders). This article reports the effects of the intervention on key implementation outcomes.
To assess changes in organizational readiness we conducted pre- and post-intervention surveys with prescribing medical providers, behavioral health providers and general clinic staff (N = 69). We report on changes in implementation outcomes: acceptability, perceptions of appropriateness and feasibility, and intention to adopt the evidence-based treatments. We used Wilcoxon signed rank tests to analyze pre- to post-intervention changes.
After 18 months, prescribing medical providers agreed more that XR-NTX was easier to use for patients with alcohol use disorders than before the intervention, but their opinions about the effectiveness and ease of use of BUP/NX for patients with opioid use disorders did not improve. Prescribing medical providers also felt more strongly after the intervention that XR-NTX for alcohol use disorders was compatible with current practices. Opinions of general clinic staff about the appropriateness of SUD treatment in primary care improved significantly.
Consistent with implementation theory, we found that an organizational readiness implementation intervention enhanced perceptions in some domains of practice acceptability and appropriateness. Further research will assess whether these factors, which focus on individual staff readiness, change over time and ultimately predict adoption of SUD treatments in primary care.
Myles J, Law F, Raybould T. A double-blind randomised controlled trial of buprenorphine/naloxone (suboxone) versus methadone/lofexidine for the detoxification of opiate-dependent addicts. Drug Alcohol Depend. 2000;60(Suppl 1):S156.
Balhara YP. Time to include buprenorphine-naloxone combination in the WHO model list of essential medicines. J Opioid Manag. 2014;9(4):237.
Bradley KA, et al. Implementation of evidence-based alcohol screening in the veterans health administration. Am J Manag Care. 2006;12(10):597–606. PubMed
Boldt R. Obstacles to the development and use of pharmacotherapies for addiction. J Health Care L & Policy. 2010;13:1–6.
Blackwell D, Lucas J, Clarke T. Summary health statistics for U.S. adults: National Health Interview Survey, 2012. Vital Health Stat. 2014;10(260):1-161.
U.S. Department of Health and Human Services Health Resources and Services Administration. The Affordable Care Act and health centers. 2013 [cited 22 Jan 2015]; Available from: http://bphc.hrsa.gov/about/healthcenterfactsheet.pdf.
Glied S, Ma S. How will the affordable care act affect services? In Issue Brief, T.C. Fund, Editor. New York and Washington, D.C: The Commonwealth Fund; 2015.
Substance Abuse and Mental Health Services Administration, results from the 2013 national survey on drug use and health: summary of national findings, NSDUH series H-46, HHS publication no. (SMA) 14–4863. Substance Abuse and Mental Health Services Administration: Rockville, MD 2014.
Luoma JB, et al. Stigma predicts treatment length in residential substance use disorder treatment. Am J Drug Alcohol Abus. 2014;40:206–12. CrossRef
Rapp RC, et al. Treatment barriers identified by substance abusers assessed at a centralized intake unit. J Subst Abus Treat. 2006;30(3):227–35. CrossRef
DeFlavio JR, et al. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. Rural Remote Health. 2015;15:3019. PubMed
Rogers E. Diffusion of innovations. 4th ed. New York: The Free Press; 1995.
Amatayakul M. EHR? Assess readiness first. Healthc Financ Manage. 2005;59(5):112–3. PubMed
Cassidy J. System analyzes readiness for integrated delivery. Health Prog. 1994;75(3):18–20. 22
O’Connor EJ, Fiol CM. Creating readiness and involvement. Physician Exec. 2006;32(1):72–4. PubMed
Greenhalgh T, et al. Diffusion of innovations in service review organizations: systematic review and recommendations. Millbank Quarterly. 2004;82(4):581–629. CrossRef
Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Admin Pol Ment Health. 2011;38(1):4–23. CrossRef
Lehman WE, Greener JM, Simpson DD. Assessing organizational readiness for change. J Subst Abus Treat. 2002;22(4):197–209. CrossRef
Glisson C, et al. Assessing the organizational social context (OSC) of mental health services: implications for research and practice. Admin Pol Ment Health. 2008;35(1–2):98–113. CrossRef
Fuller BE, et al. Organizational readiness for change and opinions toward treatment innovations. J Subst Abus Treat. 2007;33(2):183–92. CrossRef
Gotham HJ, et al. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics. J Subst Abus Treat. 2009;38(2):160–9. CrossRef
Saldana L, et al. The organizational readiness for change scale in adolescent programs: criterion validity. J Subst Abus Treat. 2007;33(2):159–69. CrossRef
Simpson DD, Joe GW, Rowan-Szal GA. Linking the elements of change: program and client responses to innovation. J Subst Abus Treat. 2007;33(2):201–9. CrossRef
Proctor E, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Admin Pol Ment Health. 2011;38(2):65–76. CrossRef
Ober AJ, et al. An organizational readiness intervention and randomized controlled trial to test strategies for implementing substance use disorder treatment into primary care: SUMMIT study protocol. Implement Sci. 2015;10
Lee JD, et al. Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months. J Subst Abus Treat. 2012;43(4):458–62. CrossRef
Hartung DM, et al. Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies. J Subst Abus Treat. 2014;47(2):113–21. CrossRef
Miller WR, Sanchez VC. Motivation of young adults for treatment and lifestyle change. In: Howard G, editor. Issues in alcohol use and misuse by young adults. Notre Dame, IN: University of Notre Dame Press; 1994. p. 55–82.
Miller WR, et al. Motivational Enhancement Therapy: A clinical research guide for therapists treating individuals with alcohol abuse and dependence, National Institute on Alcohol Abuse and Alcoholism. National Institutes of Health: Rockville; 1994.
Fixsen DL, et al. Implementation Research: A Synthesis of the Literature. New York and Washington D.C: University of South Florida, Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network (FMHI Publication #231); 2005.
Deming W. Out of the crisis, 1986, vol. 507. Cambridge, MA: Massachusetts Institute of Technology Center for Advanced Engineering Study iii; 1991.
Chinman M, Hunter S, Ebener P. Employing continuous quality improvement in community-based substance abuse programs. Int J Health Care Qual Assur. 2012;25(7):606–17. CrossRef
Hunter SB, et al. Promoting success: a getting to outcomes guide to implementing continuous quality improvement for community service organizations. Santa Monica: RAND Corporation; 2015.
Heinzerling KG, et al. SUMMIT: Procedures for Medication-Assisted Treatment of Alcohol or Opioid Dependence in Primary Care. Santa Monica: RAND Technical Manual R. Corporation; 2016.
Osilla K, et al. Brief treatment for substance use disorders: a guide for behavioral health providers. Santa Monica: R. Corporation; 2016.
Ober AJ, et al. SUMMIT study protocol: step-by-step procedures for providing screening, brief intervention and treatment services to primary care patients with alcohol or Opioid use disorders. Santa Monica: R. Corporation. In Press.
Beidas R, Kendall P. Training therapists in evidence-based practice: a critical review of studies from a systems-contextual perspective. Clin Psychol. 2010;17:1–30.
Moore G, Benbasat I. Development of an instrument to measure the perceptions of adopting an information technology innovation. Inf Syst Res. 1991;2(3):192–222. CrossRef
CASA Columbia, Missed Opportunity: Survey of Primary Care Providers and Patients on Substance Abuse. New York and Washington D.C: CASA Columbia; 2000.
Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Series B-Methodological. 1995;57(1):289–300.
Substance Abuse and Mental Health Services Administration. Buprenorphine Waiver Management. Medication-Assisted Treatment 2016 [cited 20 Dec 2016]; Available from: https://www.samhsa.gov/medication-assisted-treatment/buprenorphine-waiver-management.
- Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study
Allison J. Ober
Katherine E. Watkins
Sarah B. Hunter
Karen C. Osilla
Allison L. Diamant
Claude M. Setodji
- BioMed Central
Neu im Fachgebiet Allgemeinmedizin
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II